TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 8.74
+0.06 (0.69%)
Aug 19, 2026, 9:26 AM CST
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 6.18 billion as of August 18, 2026. Its market cap has decreased by -6.64% in one year.
Market Cap
6.18B
Enterprise Value
5.23B
Revenue
258.93M
Ranking
n/a
PE Ratio
123.41
Stock Price
8.74
ChartMarket Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 6.18B, a decrease of -85.31%. That is a compound annual growth rate of -13.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 6.18B | -35.22% |
| Dec 31, 2025 | 9.54B | 16.05% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 7.45B |
| Adimmune | 7.27B |
| Acepodia | 6.91B |
| Savior Lifetec | 6.43B |
| Sinphar Pharmaceutical | 6.02B |
| TWi Biotechnology | 5.53B |
| Steminent Biotherapeutics | 5.18B |
| AnnJi Pharmaceutical | 5.17B |